These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8458924)

  • 1. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation.
    Smitz J; Bourgain C; Van Waesberghe L; Camus M; Devroey P; Van Steirteghem AC
    Hum Reprod; 1993 Jan; 8(1):40-5. PubMed ID: 8458924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.
    Smitz J; Devroey P; Camus M; Deschacht J; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Jul; 3(5):585-90. PubMed ID: 3139698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement.
    Smitz J; Devroey P; Faguer B; Bourgain C; Camus M; Van Steirteghem AC
    Hum Reprod; 1992 Feb; 7(2):168-75. PubMed ID: 1577927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hormonal changes during combined buserelin/HMG treatment.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
    Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles.
    Bourgain C; Smitz J; Camus M; Erard P; Devroey P; Van Steirteghem AC; Kloppel G
    Hum Reprod; 1994 Jan; 9(1):32-40. PubMed ID: 8195348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.
    Smitz J; Erard P; Camus M; Devroey P; Tournaye H; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1992 Oct; 7(9):1225-9. PubMed ID: 1479002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
    Weissman A; Loumaye E; Shoham Z
    Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of corpus luteum function.
    Johnson MR; Abbas AA; Irvine R; Riddle AF; Norman-Taylor JQ; Grudzinskas JG; Collins WP; Nicolaides KH
    Hum Reprod; 1994 Jan; 9(1):41-8. PubMed ID: 8195349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and histological evaluation of the luteal phase after combined GnRH-agonist/gonadotrophin treatment for superovulation and luteal phase support in in-vitro fertilization.
    Balasch J; Jové I; Márquez M; Vanrell JA
    Hum Reprod; 1991 Aug; 6(7):914-7. PubMed ID: 1761657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone.
    Romàn E; Aytoz A; Smitz JE; Faguer B; Camus M; Van Steirteghem AC; Devroey P
    Hum Reprod; 2000 Jul; 15(7):1435-9. PubMed ID: 10875847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist.
    Lelaidier C; de Ziegler D; Gaetano J; Hazout A; Fernandez H; Frydman R
    Hum Reprod; 1992 Nov; 7(10):1353-6. PubMed ID: 1291558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route].
    Smitz J; Devroey P; Faguer B; Bourgain C; Camus M; Van Steirteghem AC
    Rev Fr Gynecol Obstet; 1992 Oct; 87(10):507-16. PubMed ID: 1470824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.